Filovirus vaccines: what challenges are left?

Click to increase image sizeClick to decrease image size

Acknowledgements

The authors thank Mike Bray (NIAID) for his helpful comments.

Financial & competing interests disclosure

The authors were supported by the NIAID Intramural Program. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.